Home
Organic reaction
Organic synthesis
►Pfizer
►Roche
►Merck
►Galapagos
►Astrazeneca
►GSK
►Novartis
►Sanofi-aventis
WO2010000353
WO2010003624
WO2010004197
WO2010004198
WO2010004215
WO2010006704
WO2010007316
WO2010007317
WO2010007318
WO2010010288
WO2010012964
WO2010013078
WO2010018327
WO2010018328
WO2010018329
WO2010022196
WO2010025856
WO2010028761
WO2010049635
WO2010055267
WO2010063929
WO2010065571
WO2010065798
WO2010065803
WO2010070237
WO2010070238
►Janssen
►Amgen
Synthetic protocols
Organic and Medicinal Chemistry News
Pharmaceuticals Patents News
Universities and Institutes Patents News
Contact
WO2010018329 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
WO2010018329.pdf
Adobe Acrobat Document [1.6 MB]
Download
Biological target:
Cannabinoid receptor type :
CB1
Activity:
Modulator
Site Search
Newsletter
Enter your email address to get our newsletter.
Close